Neurocritical Care Society

Leading Insights

Cefepime’s Double-Edged Sword: Neurotoxicity in Critically Ill Patients

Written By: Michelle Payne, PharmD, BCCCP

As a fourth-generation anti-Pseudomonal cephalosporin, cefepime is one of the first-line antimicrobials used to treat various hospital-associated...

More Leading Insights

Breaking Barriers: How Brazil’s RESILIENT Trials Redefined Stroke Research in Latin America

Written By: Gisele Sampaio Silva; Sheila Martins; Clio Rubinos, MD, MS, FACNS

The RESILIENT¹and RESILIENT-EXTEND trials have been landmark studies, not just in Brazil, but across the global stroke community.

Using Transorbital Doppler and IMPRESSIT To Evaluate Intracranial Pressure in a Patient With Aneurysmal SAH

Written By: Tyler Spivey, MD; Ann Lin, MD; Brittany M. Kasturiarachi, DO

A 66-year-old woman presented with sudden-onset headache and a brief loss of consciousness. CT head revealed diffuse aneurysmal subarachnoid...

Global Barriers to Antiseizure Medications in Resource-Limited Settings: Challenges and Solutions & A Call to Action

Written By: Renad Abu-Sawwa, PharmD, BCPPS

The World Health Organization (WHO) reports estimate of about 50 million people worldwide have epilepsy – 80% of which reside in low- and...